 | • レポートコード：MRC2102QY9861 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のNSAID市場について種類別（アスピリン、イブプロフェン、ナプロキセン、ナブメトン、その他）、用途別（腰痛治療、変形性関節症治療、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・NSAID市場の概要 ・世界の主要地域別NSAID市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のNSAID市場規模2015-2026：種類別（アスピリン、イブプロフェン、ナプロキセン、ナブメトン、その他） ・世界のNSAID市場規模2015-2026：用途別（腰痛治療、変形性関節症治療、その他） ・NSAIDの米国市場規模2015-2020 ・NSAIDのヨーロッパ市場規模2015-2020 ・NSAIDの中国市場規模2015-2020 ・NSAIDの日本市場規模2015-2020 ・NSAIDの東南アジア市場規模2015-2020 ・NSAIDのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・NSAIDの製造コスト分析 ・販売チャネル、流通業者、顧客 ・NSAIDの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global NSAIDs Market
The global NSAIDs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global NSAIDs Scope and Market Size
The global NSAIDs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NSAIDs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the NSAIDs market is segmented into
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application, the NSAIDs market is segmented into
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
The NSAIDs market is analysed and market size information is provided by regions (countries). Segment by Application, the NSAIDs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and NSAIDs Market Share Analysis
NSAIDs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NSAIDs business, the date to enter into the NSAIDs market, NSAIDs product introduction, recent developments, etc.
The major vendors covered:
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
1 NSAIDs Market Overview
1.1 NSAIDs Product Scope
1.2 NSAIDs Segment by Type
1.2.1 Global NSAIDs Sales by Type (2020-2026)
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Nabumetone
1.2.6 Others
1.3 NSAIDs Segment by Application
1.3.1 Global NSAIDs Sales Comparison by Application (2020-2026)
1.3.2 Back Pain Treatment
1.3.3 Osteoarthritis Treatment
1.3.4 Other Disease Treatment
1.4 NSAIDs Market Estimates and Forecasts (2015-2026)
1.4.1 Global NSAIDs Sales Growth Rate (2015-2026)
1.4.2 Global NSAIDs Revenue and Growth Rate (2015-2026)
1.4.3 Global NSAIDs Price Trends (2015-2026)
2 NSAIDs Estimate and Forecast by Region
2.1 Global NSAIDs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global NSAIDs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global NSAIDs Sales Market Share by Region (2015-2020)
2.2.2 Global NSAIDs Revenue Market Share by Region (2015-2020)
2.3 Global NSAIDs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global NSAIDs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global NSAIDs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States NSAIDs Estimates and Projections (2015-2026)
2.4.2 Europe NSAIDs Estimates and Projections (2015-2026)
2.4.3 China NSAIDs Estimates and Projections (2015-2026)
2.4.4 Japan NSAIDs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia NSAIDs Estimates and Projections (2015-2026)
2.4.6 India NSAIDs Estimates and Projections (2015-2026)
3 Global NSAIDs Competition Landscape by Players
3.1 Global Top NSAIDs Players by Sales (2015-2020)
3.2 Global Top NSAIDs Players by Revenue (2015-2020)
3.3 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs as of 2019)
3.4 Global NSAIDs Average Price by Company (2015-2020)
3.5 Manufacturers NSAIDs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key NSAIDs Players (Opinion Leaders)
4 Global NSAIDs Market Size by Type
4.1 Global NSAIDs Historic Market Review by Type (2015-2020)
4.1.1 Global NSAIDs Sales Market Share by Type (2015-2020)
4.1.2 Global NSAIDs Revenue Market Share by Type (2015-2020)
4.1.3 Global NSAIDs Price by Type (2015-2020)
4.2 Global NSAIDs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global NSAIDs Sales Forecast by Type (2021-2026)
4.2.2 Global NSAIDs Revenue Forecast by Type (2021-2026)
4.2.3 Global NSAIDs Price Forecast by Type (2021-2026)
5 Global NSAIDs Market Size by Application
5.1 Global NSAIDs Historic Market Review by Application (2015-2020)
5.1.1 Global NSAIDs Sales Market Share by Application (2015-2020)
5.1.2 Global NSAIDs Revenue Market Share by Application (2015-2020)
5.1.3 Global NSAIDs Price by Application (2015-2020)
5.2 Global NSAIDs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global NSAIDs Sales Forecast by Application (2021-2026)
5.2.2 Global NSAIDs Revenue Forecast by Application (2021-2026)
5.2.3 Global NSAIDs Price Forecast by Application (2021-2026)
6 United States NSAIDs Market Facts & Figures
6.1 United States NSAIDs Sales Market Share by Company (2015-2020)
6.2 United States NSAIDs Sales Market Share by Type (2015-2020)
6.3 United States NSAIDs Sales Market Share by Application (2015-2020)
7 Europe NSAIDs Market Facts & Figures
7.1 Europe NSAIDs Sales Market Share by Company (2015-2020)
7.2 Europe NSAIDs Sales Market Share by Type (2015-2020)
7.3 Europe NSAIDs Sales Market Share by Application (2015-2020)
8 China NSAIDs Market Facts & Figures
8.1 China NSAIDs Sales Market Share by Company (2015-2020)
8.2 China NSAIDs Sales Market Share by Type (2015-2020)
8.3 China NSAIDs Sales Market Share by Application (2015-2020)
9 Japan NSAIDs Market Facts & Figures
9.1 Japan NSAIDs Sales Market Share by Company (3015-3030)
9.2 Japan NSAIDs Sales Market Share by Type (2015-2020)
9.3 Japan NSAIDs Sales Market Share by Application (2015-2020)
10 Southeast Asia NSAIDs Market Facts & Figures
10.1 Southeast Asia NSAIDs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia NSAIDs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia NSAIDs Sales Market Share by Application (2015-2020)
11 India NSAIDs Market Facts & Figures
11.1 India NSAIDs Sales Market Share by Company (2015-2020)
11.2 India NSAIDs Sales Market Share by Type (2015-2020)
11.3 India NSAIDs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in NSAIDs Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer NSAIDs Products Offered
12.1.5 Bayer Recent Development
12.2 Novacap
12.2.1 Novacap Corporation Information
12.2.2 Novacap Business Overview
12.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novacap NSAIDs Products Offered
12.2.5 Novacap Recent Development
12.3 Abbott
12.3.1 Abbott Corporation Information
12.3.2 Abbott Business Overview
12.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott NSAIDs Products Offered
12.3.5 Abbott Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer NSAIDs Products Offered
12.4.5 Pfizer Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Business Overview
12.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson NSAIDs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Cigna
12.6.1 Cigna Corporation Information
12.6.2 Cigna Business Overview
12.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Cigna NSAIDs Products Offered
12.6.5 Cigna Recent Development
12.7 Geri-Care Pharmaceuticals
12.7.1 Geri-Care Pharmaceuticals Corporation Information
12.7.2 Geri-Care Pharmaceuticals Business Overview
12.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
12.7.5 Geri-Care Pharmaceuticals Recent Development
12.8 Perrigo Company
12.8.1 Perrigo Company Corporation Information
12.8.2 Perrigo Company Business Overview
12.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Perrigo Company NSAIDs Products Offered
12.8.5 Perrigo Company Recent Development
12.9 Kopran
12.9.1 Kopran Corporation Information
12.9.2 Kopran Business Overview
12.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Kopran NSAIDs Products Offered
12.9.5 Kopran Recent Development
12.10 Merck Sharp & Dohme
12.10.1 Merck Sharp & Dohme Corporation Information
12.10.2 Merck Sharp & Dohme Business Overview
12.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck Sharp & Dohme NSAIDs Products Offered
12.10.5 Merck Sharp & Dohme Recent Development
12.11 Sun Pharmaceutical Industries
12.11.1 Sun Pharmaceutical Industries Corporation Information
12.11.2 Sun Pharmaceutical Industries Business Overview
12.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sun Pharmaceutical Industries NSAIDs Products Offered
12.11.5 Sun Pharmaceutical Industries Recent Development
12.12 GlaxoSmithKline
12.12.1 GlaxoSmithKline Corporation Information
12.12.2 GlaxoSmithKline Business Overview
12.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 GlaxoSmithKline NSAIDs Products Offered
12.12.5 GlaxoSmithKline Recent Development
12.13 Reddy Pharmaceuticals
12.13.1 Reddy Pharmaceuticals Corporation Information
12.13.2 Reddy Pharmaceuticals Business Overview
12.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Reddy Pharmaceuticals NSAIDs Products Offered
12.13.5 Reddy Pharmaceuticals Recent Development
12.14 Verywell
12.14.1 Verywell Corporation Information
12.14.2 Verywell Business Overview
12.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Verywell NSAIDs Products Offered
12.14.5 Verywell Recent Development
13 NSAIDs Manufacturing Cost Analysis
13.1 NSAIDs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of NSAIDs
13.4 NSAIDs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 NSAIDs Distributors List
14.3 NSAIDs Customers
15 Market Dynamics
15.1 NSAIDs Market Trends
15.2 NSAIDs Opportunities and Drivers
15.3 NSAIDs Market Challenges
15.4 NSAIDs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global NSAIDs Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global NSAIDs Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market NSAIDs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global NSAIDs Sales (MT) by Region (2015-2020)
Table 5. Global NSAIDs Sales Market Share by Region (2015-2020)
Table 6. Global NSAIDs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global NSAIDs Revenue Share by Region (2015-2020)
Table 8. Global NSAIDs Sales (MT) Forecast by Region (2021-2026)
Table 9. Global NSAIDs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global NSAIDs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global NSAIDs Revenue Share Forecast by Region (2021-2026)
Table 12. Global NSAIDs (MT) of Key Companies (2015-2020)
Table 13. Global NSAIDs Sales Share by Company (2015-2020)
Table 14. Global NSAIDs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global NSAIDs Revenue Share by Company (2015-2020)
Table 16. Global NSAIDs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs as of 2019)
Table 17. Global NSAIDs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers NSAIDs Manufacturing Sites and Area Served
Table 19. Manufacturers NSAIDs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key NSAIDs Players
Table 22. Global NSAIDs Sales (MT) by Type (2015-2020)
Table 23. Global NSAIDs Sales Share by Type (2015-2020)
Table 24. Global NSAIDs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global NSAIDs Price (MT) by Type (2015-2020)
Table 26. Global NSAIDs Sales Share by Type (2021-2026)
Table 27. Global NSAIDs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global NSAIDs Revenue Share by Type (2021-2026)
Table 29. Global NSAIDs Price (MT) by Type (2021-2026)
Table 30. Global NSAIDs Sales (MT) by Application (2015-2020)
Table 31. Global NSAIDs Sales Share by Application (2015-2020)
Table 32. Global NSAIDs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global NSAIDs Price (MT) by Application (2015-2020)
Table 34. Global NSAIDs Sales (MT) by Application (2021-2026)
Table 35. Global NSAIDs Sales Share by Application (2021-2026)
Table 36. Global NSAIDs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global NSAIDs Revenue Share by Application (2021-2026)
Table 38. Global NSAIDs Price (MT) by Application (2021-2026)
Table 39. United States NSAIDs Sales (MT) by Company (2015-2020)
Table 40. United States NSAIDs Sales Market Share by Company (2015-2020)
Table 41. United States NSAIDs Sales (MT) by Type (2015-2020)
Table 42. United States NSAIDs Sales Market Share by Type (2015-2020)
Table 43. United States NSAIDs Sales (MT) by Application (2015-2020)
Table 44. United States NSAIDs Sales Market Share by Application (2015-2020)
Table 45. Europe NSAIDs Sales (MT) by Company (2015-2020)
Table 46. Europe NSAIDs Sales Market Share by Company (2015-2020)
Table 47. Europe NSAIDs Sales (MT) by Type (2015-2020)
Table 48. Europe NSAIDs Sales Market Share by Type (2015-2020)
Table 49. Europe NSAIDs Sales (MT) by Application (2015-2020)
Table 50. Europe NSAIDs Sales Market Share by Type (2015-2020)
Table 51. China NSAIDs Sales (MT) by Company (2015-2020)
Table 52. China NSAIDs Sales Market Share by Company (2015-2020)
Table 53. China NSAIDs Sales (MT) by Type (2015-2020)
Table 54. China NSAIDs Sales Market Share by Type (2015-2020)
Table 55. China NSAIDs Sales (MT) by Application (2015-2020)
Table 56. China NSAIDs Sales Market Share by Application (2015-2020)
Table 57. Japan NSAIDs Sales (MT) by Company (2015-2020)
Table 58. Japan NSAIDs Sales Market Share by Company (2015-2020)
Table 59. Japan NSAIDs Sales (MT) by Type (2015-2020)
Table 60. Japan NSAIDs Sales Market Share by Type (2015-2020)
Table 61. Japan NSAIDs Sales (MT) by Application (2015-2020)
Table 62. Japan NSAIDs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia NSAIDs Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia NSAIDs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia NSAIDs Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia NSAIDs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia NSAIDs Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia NSAIDs Sales Market Share by Application (2015-2020)
Table 69. India NSAIDs Sales (MT) by Company (2015-2020)
Table 70. India NSAIDs Sales Market Share by Company (2015-2020)
Table 71. India NSAIDs Sales (MT) by Type (2015-2020)
Table 72. India NSAIDs Sales Market Share by Type (2015-2020)
Table 73. India NSAIDs Sales (MT) by Application (2015-2020)
Table 74. India NSAIDs Sales Market Share by Application (2015-2020)
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer NSAIDs Product
Table 79. Bayer Recent Development
Table 80. Novacap Corporation Information
Table 81. Novacap Description and Business Overview
Table 82. Novacap NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novacap NSAIDs Product
Table 84. Novacap Recent Development
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Abbott NSAIDs Product
Table 89. Abbott Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer NSAIDs Product
Table 94. Pfizer Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson NSAIDs Product
Table 99. Johnson & Johnson Recent Development
Table 100. Cigna Corporation Information
Table 101. Cigna Description and Business Overview
Table 102. Cigna NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Cigna NSAIDs Product
Table 104. Cigna Recent Development
Table 105. Geri-Care Pharmaceuticals Corporation Information
Table 106. Geri-Care Pharmaceuticals Description and Business Overview
Table 107. Geri-Care Pharmaceuticals NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Geri-Care Pharmaceuticals NSAIDs Product
Table 109. Geri-Care Pharmaceuticals Recent Development
Table 110. Perrigo Company Corporation Information
Table 111. Perrigo Company NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Perrigo Company Description and Business Overview
Table 113. Perrigo Company NSAIDs Product
Table 114. Perrigo Company Recent Development
Table 115. Kopran Corporation Information
Table 116. Kopran NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Kopran Description and Business Overview
Table 118. Kopran NSAIDs Product
Table 119. Kopran Recent Development
Table 120. Merck Sharp & Dohme Corporation Information
Table 121. Merck Sharp & Dohme Description and Business Overview
Table 122. Merck Sharp & Dohme NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Merck Sharp & Dohme NSAIDs Product
Table 124. Merck Sharp & Dohme Recent Development
Table 125. Sun Pharmaceutical Industries Corporation Information
Table 126. Sun Pharmaceutical Industries Description and Business Overview
Table 127. Sun Pharmaceutical Industries NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Sun Pharmaceutical Industries NSAIDs Product
Table 129. Sun Pharmaceutical Industries Recent Development
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Business Overview
Table 132. GlaxoSmithKline NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. GlaxoSmithKline NSAIDs Product
Table 134. GlaxoSmithKline Recent Development
Table 135. Reddy Pharmaceuticals Corporation Information
Table 136. Reddy Pharmaceuticals Description and Business Overview
Table 137. Reddy Pharmaceuticals NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Reddy Pharmaceuticals NSAIDs Product
Table 139. Reddy Pharmaceuticals Recent Development
Table 140. Verywell Corporation Information
Table 141. Verywell Description and Business Overview
Table 142. Verywell NSAIDs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Verywell NSAIDs Product
Table 144. Verywell Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. NSAIDs Distributors List
Table 148. NSAIDs Customers List
Table 149. NSAIDs Market Key Trends
Table 150. NSAIDs Key Opportunities and Drivers
Table 151. NSAIDs Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. NSAIDs Product Picture
Figure 2. Global NSAIDs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global NSAIDs Market Share by Application in 2020 & 2026
Figure 6. Back Pain Treatment Examples
Figure 7. Osteoarthritis Treatment Examples
Figure 8. Other Disease Treatment Examples
Figure 9. Global NSAIDs Sales (MT) Growth Rate (2015-2026)
Figure 10. Global NSAIDs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global NSAIDs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global NSAIDs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global NSAIDs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States NSAIDs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States NSAIDs Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe NSAIDs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe NSAIDs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China NSAIDs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China NSAIDs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan NSAIDs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan NSAIDs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia NSAIDs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia NSAIDs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India NSAIDs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India NSAIDs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest NSAIDs Players Market Share by Revenue in NSAIDs 2015 & 2019
Figure 27. NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global NSAIDs Revenue Share by Type (2015-2020)
Figure 29. Global NSAIDs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global NSAIDs Revenue Share by Application (2015-2020)
Figure 31. Global NSAIDs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States NSAIDs Sales Market Share by Type in 2019
Figure 33. United States NSAIDs Sales Market Share by Type in 2019
Figure 34. Europe NSAIDs Sales Market Share by Company in 2019
Figure 35. Europe NSAIDs Sales Market Share by Type in 2019
Figure 36. Europe NSAIDs Sales Market Share by Application in 2019
Figure 37. China NSAIDs Sales Market Share by Company in 2019
Figure 38. China NSAIDs Sales Market Share by Type in 2019
Figure 39. China NSAIDs Sales Market Share by Application in 2019
Figure 40. Japan NSAIDs Sales Market Share by Company in 2019
Figure 41. Japan NSAIDs Sales Market Share by Type in 2019
Figure 42. Japan NSAIDs Sales Market Share by Application in 2019
Figure 43. Southeast Asia NSAIDs Sales Market Share by Company in 2019
Figure 44. Southeast Asia NSAIDs Sales Market Share by Type in 2019
Figure 45. Southeast Asia NSAIDs Sales Market Share by Application in 2019
Figure 46. India NSAIDs Sales Market Share by Company in 2019
Figure 47. India NSAIDs Sales Market Share by Type in 2019
Figure 48. India NSAIDs Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of NSAIDs
Figure 51. Manufacturing Process Analysis of NSAIDs
Figure 52. NSAIDs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
腎疾患治療装置の世界市場レポート2020 Renal Disease Treatment Devices are subdivided into urinary treatment, dialysis, pelvic organ prolapse treatment, endoscopic, benign prostatic hyperplasia treatment equipment, prostate stent, gravel, sacral nerve regulation, urethral insertion and pessary, urethral stent, vaginal network Sleeve and …- 特発性振戦治療の世界市場レポート2020 Market Analysis and Insights: Global Essential Tremor Treatment Market The global Essential Tremor Treatment market size is projected to reach US$ 205 million by 2026, from US$ 152.1 million in 2020, at a CAGR of 5.1% during 2021-2026. Global Essential Tremor Treatment Scope and Market Size The glob…
- 天然ガス処理の世界市場レポート2020 Market Analysis and Insights: Global Natural Gas Treatment Market The global Natural Gas Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Natural Gas Treatment Scope and Market Size The global Natural Gas Treat…
- 真空熱処理機器の世界市場レポート2020 Market Analysis and Insights: Global Vacuum Heat Treatment Equipment Market The global Vacuum Heat Treatment Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Vacuum Heat Treatment Equipment Scope and Market Siz…
- 外陰部痛治療の世界市場レポート2020 Market Analysis and Insights: Global Vulvodynia Treatment Market The global Vulvodynia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Vulvodynia Treatment Scope and Market Size The global Vulvodynia Treatment…